Close

Ratings by H.C. Wainwright (Douglas Tsao)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
2/26/2024 Revance Therapeutic RVNC Maintain Buy
(N/A)
 
 
  Details
2/16/2024 Sage Therapeutics SAGE Maintain Neutral
(N/A)
 
 
  Details
2/16/2024 Alkermes ALKS Maintain Neutral
(N/A)
 
 
  Details
2/15/2024 Outlook Therapeutics Incs. OTLK Maintain Buy
(N/A)
 
 
  Details
2/12/2024 Sage Therapeutics SAGE Maintain Neutral
(N/A)
 
 
  Details
2/9/2024 Sage Therapeutics SAGE Maintain Neutral
(N/A)
 
 
  Details
1/17/2024 Apellis Pharmaceuticals APLS Maintain Buy
(N/A)
 
 
  Details
12/22/2023 Biohaven Pharmaceutical Holding BHVN New Coverage Buy
(N/A)
38.02
(47.66)
25.36% Details
12/21/2023 Immunovant IMVT Maintain Buy
(N/A)
 
 
  Details
12/21/2023 argenx SE ARGX Maintain Buy
(N/A)
 
 
  Details
12/20/2023 Crinetics CRNX Maintain Buy
(N/A)
 
 
  Details
12/7/2023 Cerevel Therapeutics CERE Downgrade Neutral
(Buy)
36.93
(41.31)
11.86% Details
12/1/2023 Praxis Precision Medicines Inc. PRAX Maintain Buy
(N/A)
 
 
  Details
11/29/2023 argenx SE ARGX Maintain Buy
(N/A)
 
 
  Details
11/6/2023 Revance Therapeutic RVNC Maintain Buy
(N/A)
 
 
  Details
11/3/2023 Outlook Therapeutics Incs. OTLK Upgrade Buy
(Neutral)
0.34
(0.44)
29.41% Details
10/24/2023 Immunovant IMVT Maintain Buy
(N/A)
 
 
  Details
8/31/2023 Outlook Therapeutics Incs. OTLK Downgrade Neutral
(Buy)
0.27
(0.44)
62.96% Details
8/18/2023 AEON Biopharma, Inc AEON New Coverage Buy
(N/A)
4.34
(12.12)
179.26% Details
8/14/2023 Disc Medicine IRON Maintain Buy
(N/A)
 
 
  Details
8/10/2023 Praxis Precision Medicines Inc. PRAX Maintain Buy
(N/A)
 
 
  Details
8/10/2023 Viridian Therapeutic VRDN Maintain Buy
(N/A)
 
 
  Details
8/8/2023 Sage Therapeutics SAGE Maintain Neutral
(N/A)
 
 
  Details
8/3/2023 Cerevel Therapeutics CERE Maintain Buy
(N/A)
 
 
  Details
8/3/2023 Evolus EOLS Maintain Buy
(N/A)
 
 
  Details
8/2/2023 Minerva Neurosciences NERV Maintain Neutral
(N/A)
 
 
  Details
7/21/2023 Apellis Pharmaceuticals APLS Maintain Buy
(N/A)
 
 
  Details
7/21/2023 argenx SE ARGX Maintain Buy
(N/A)
 
 
  Details
7/18/2023 Immunovant IMVT Maintain Buy
(N/A)
 
 
  Details
6/29/2023 Roivant Sciences ROIV Maintain Buy
(N/A)
 
 
  Details
6/12/2023 Disc Medicine IRON Maintain Buy
(N/A)
 
 
  Details
6/7/2023 Disc Medicine IRON New Coverage Buy
(N/A)
39.17
(66.25)
69.13% Details
5/24/2023 Immunovant IMVT Maintain Buy
(N/A)
 
 
  Details
5/17/2023 Roivant Sciences ROIV Maintain Buy
(N/A)
 
 
  Details
5/15/2023 Rezolute RZLT Maintain Buy
(N/A)
 
 
  Details
5/12/2023 Praxis Precision Medicines Inc. PRAX Maintain Buy
(N/A)
 
 
  Details
5/11/2023 Evolus EOLS Maintain Buy
(N/A)
 
 
  Details
5/10/2023 Revance Therapeutic RVNC Maintain Buy
(N/A)
 
 
  Details
5/5/2023 argenx SE ARGX Maintain Buy
(N/A)
 
 
  Details
4/27/2023 Alkermes ALKS Maintain Neutral
(N/A)
 
 
  Details
3/20/2023 Immunovant IMVT Maintain Buy
(N/A)
 
 
  Details
3/17/2023 Cabaletta Bio Inc. CABA Maintain Buy
(N/A)
 
 
  Details
3/17/2023 Protagonist Therapeutics PTGX Maintain Buy
(N/A)
 
 
  Details
3/9/2023 Viridian Therapeutic VRDN Maintain Buy
(N/A)
 
 
  Details
2/23/2023 Cerevel Therapeutics CERE Maintain Buy
(N/A)
 
 
  Details
2/21/2023 Apellis Pharmaceuticals APLS Maintain Buy
(N/A)
 
 
  Details
2/14/2023 Rezolute RZLT Maintain Buy
(N/A)
 
 
  Details
2/7/2023 Immunovant IMVT Maintain Buy
(N/A)
 
 
  Details
2/3/2023 Praxis Precision Medicines Inc. PRAX Maintain Buy
(N/A)
 
 
  Details
1/10/2023 argenx SE ARGX Maintain Buy
(N/A)
 
 
  Details
1/6/2023 Outlook Therapeutics Incs. OTLK Maintain Buy
(N/A)
 
 
  Details
12/13/2022 Dare Bioscience DARE Maintain Buy
(N/A)
 
 
  Details
11/10/2022 scPharmaceuticals SCPH Maintain Buy
(N/A)
 
 
  Details
11/10/2022 Protagonist Therapeutics PTGX Maintain Buy
(N/A)
 
 
  Details
11/10/2022 Minerva Neurosciences NERV Downgrade Neutral
(Buy)
3.26
(2.80)
-14.11% Details
11/9/2022 Marinus Pharmaceuticals MRNS Maintain Buy
(N/A)
 
 
  Details
11/9/2022 Sage Therapeutics SAGE Maintain Neutral
(N/A)
 
 
  Details
11/9/2022 Cerevel Therapeutics CERE Maintain Buy
(N/A)
 
 
  Details
11/7/2022 Immunovant IMVT Maintain Buy
(N/A)
 
 
  Details
11/1/2022 Horizon Therapeutics HZNP New Coverage Neutral
(N/A)
62.32
(116.30)
86.62% Details
10/18/2022 Minerva Neurosciences NERV Maintain Buy
(N/A)
 
 
  Details
9/9/2022 Revance Therapeutic RVNC Maintain Buy
(N/A)
 
 
  Details
8/1/2022 argenx SE ARGX Maintain Neutral
(N/A)
 
 
  Details
7/19/2022 Apellis Pharmaceuticals APLS New Coverage Buy
(N/A)
44.76
(69.35)
54.94% Details
6/7/2022 Praxis Precision Medicines Inc. PRAX Maintain Buy
(N/A)
 
 
  Details
5/11/2022 Biohaven Pharmaceutical Holding BHVN Downgrade Neutral
(Buy)
140.00
(47.66)
-65.96% Details
3/4/2022 Minerva Neurosciences NERV Maintain Buy
(N/A)
 
 
  Details
3/1/2022 Revance Therapeutic RVNC Maintain Buy
(N/A)
 
 
  Details
12/23/2021 Osmotica OSMT New Coverage Buy
(N/A)
1.06
(1.11)
4.72% Details
12/16/2021 Praxis Precision Medicines Inc. PRAX New Coverage Buy
(N/A)
18.10
(48.84)
169.83% Details
12/16/2021 Cerevel Therapeutics CERE New Coverage Buy
(N/A)
30.44
(41.31)
35.71% Details
11/9/2021 Radius Health RDUS Maintain Neutral
(N/A)
 
 
  Details
10/18/2021 Revance Therapeutic RVNC Maintain Buy
(N/A)
 
 
  Details
10/13/2021 Revance Therapeutic RVNC Maintain Buy
(N/A)
 
 
  Details
10/6/2021 Biohaven Pharmaceutical Holding BHVN Maintain Buy
(N/A)
 
 
  Details
8/3/2021 Outlook Therapeutics Incs. OTLK Maintain Buy
(N/A)
 
 
  Details
7/8/2021 Biohaven Pharmaceutical Holding BHVN Maintain Buy
(N/A)
 
 
  Details
6/21/2021 Protagonist Therapeutics PTGX Maintain Buy
(N/A)
 
 
  Details
5/25/2021 Rezolute RZLT New Coverage Buy
(N/A)
6.45
(1.69)
-73.8% Details
5/10/2021 Immunovant IMVT Maintain Buy
(N/A)
 
 
  Details
5/10/2021 argenx SE ARGX Upgrade Buy
(Neutral)
263.70
(411.20)
55.93% Details
5/6/2021 Chiasma CHMA Maintain Buy
(N/A)
 
 
  Details
4/29/2021 Alkermes ALKS Maintain Buy
(N/A)
 
 
  Details
3/23/2021 Protagonist Therapeutics PTGX Maintain Buy
(N/A)
 
 
  Details
3/11/2021 Protagonist Therapeutics PTGX Maintain Buy
(N/A)
 
 
  Details
3/2/2021 Chiasma CHMA Maintain Buy
(N/A)
 
 
  Details
2/22/2021 Evolus EOLS Maintain Buy
(N/A)
 
 
  Details
2/4/2021 GW Pharma GWPH Downgrade Buy
(Buy)
211.37
(218.96)
3.59% Details
12/18/2020 Dare Bioscience DARE New Coverage Buy
(N/A)
1.13
(0.50)
-55.75% Details
12/15/2020 GW Pharma GWPH New Coverage Buy
(N/A)
121.22
(218.96)
80.63% Details
11/6/2020 Sage Therapeutics SAGE Maintain Buy
(N/A)
 
 
  Details
10/13/2020 Cabaletta Bio Inc. CABA New Coverage Buy
(N/A)
11.28
(24.32)
115.6% Details
10/2/2020 AMAG Pharmaceuticals AMAG Downgrade Neutral
(Buy)
13.65
(13.75)
0.73% Details
8/27/2020 Outlook Therapeutics Incs. OTLK Maintain Buy
(N/A)
 
 
  Details
8/26/2020 Immunovant IMVT Maintain Buy
(N/A)
 
 
  Details
8/25/2020 Momenta Pharmaceuticals MNTA Downgrade Neutral
(Buy)
52.15
(52.48)
0.63% Details
8/12/2020 Chiasma CHMA Maintain Buy
(N/A)
 
 
  Details
8/6/2020 AMAG Pharmaceuticals AMAG Maintain Buy
(N/A)
 
 
  Details
8/4/2020 GW Pharma GWPH Maintain Buy
(N/A)
 
 
  Details
7/29/2020 Momenta Pharmaceuticals MNTA Maintain Buy
(N/A)
 
 
  Details
7/29/2020 Immunovant IMVT New Coverage Buy
(N/A)
23.32
(38.36)
64.49% Details
7/29/2020 argenx SE ARGX New Coverage Neutral
(N/A)
253.23
(411.20)
62.38% Details
7/1/2020 Marinus Pharmaceuticals MRNS Maintain Buy
(N/A)
 
 
  Details
6/29/2020 Chiasma CHMA Maintain Buy
(N/A)
 
 
  Details
6/16/2020 Momenta Pharmaceuticals MNTA Maintain Buy
(N/A)
 
 
  Details
6/8/2020 Minerva Neurosciences NERV Maintain Buy
(N/A)
 
 
  Details
6/8/2020 Minerva Neurosciences NERV Maintain Buy
(Buy)
 
 
  Details
5/27/2020 Outlook Therapeutics Incs. OTLK Maintain Buy
(Buy)
 
 
  Details
5/18/2020 Protagonist Therapeutics PTGX Maintain Buy
(N/A)
 
 
  Details
5/13/2020 scPharmaceuticals SCPH Maintain Buy
(N/A)
 
 
  Details
5/12/2020 AMAG Pharmaceuticals AMAG Maintain Buy
(N/A)
 
 
  Details
4/17/2020 AMAG Pharmaceuticals AMAG Maintain Buy
(N/A)
 
 
  Details
2/27/2020 GW Pharma GWPH Maintain Buy
(N/A)
 
 
  Details
2/26/2020 Revance Therapeutic RVNC Maintain Buy
(N/A)
 
 
  Details
2/26/2020 Evolus EOLS Maintain Buy
(N/A)
 
 
  Details
2/25/2020 Theravance Biopharma TBPH Maintain Buy
(N/A)
 
 
  Details
1/23/2020 Dermira DERM Downgrade Neutral
(Buy)
18.83
(4.06)
-78.44% Details
10/30/2019 AMAG Pharmaceuticals AMAG Maintain Buy
(Buy)
 
 
  Details
10/30/2019 Sage Therapeutics SAGE New Coverage Neutral
(N/A)
140.16
(22.71)
-83.8% Details
10/30/2019 GW Pharma GWPH New Coverage Buy
(N/A)
134.06
(218.96)
63.33% Details
10/15/2019 scPharmaceuticals SCPH New Coverage Buy
(N/A)
5.90
(6.22)
5.42% Details
9/25/2019 Momenta Pharmaceuticals MNTA New Coverage Buy
(N/A)
13.10
(52.48)
300.61% Details
9/4/2019 Trevena TRVN Maintain Buy
(Buy)
 
 
  Details
7/18/2019 Outlook Therapeutics Incs. OTLK New Coverage Buy
(N/A)
2.02
(0.44)
-78.22% Details
7/8/2019 Protagonist Therapeutics PTGX New Coverage Buy
(N/A)
12.50
(29.59)
136.72% Details
5/31/2019 Trevena TRVN New Coverage Buy
(N/A)
1.19
(0.58)
-51.26% Details
3/27/2019 Dermira DERM Maintain Buy
(N/A)
 
 
  Details
2/14/2019 Radius Health RDUS New Coverage Neutral
(N/A)
19.60
(23.98)
22.35% Details
2/14/2019 Crinetics CRNX New Coverage Buy
(N/A)
24.86
(40.47)
62.79% Details
2/14/2019 Revance Therapeutic RVNC New Coverage Buy
(N/A)
17.86
(5.70)
-68.09% Details
2/14/2019 Evolus EOLS New Coverage Buy
(N/A)
26.56
(14.54)
-45.26% Details
2/14/2019 Chiasma CHMA New Coverage Buy
(N/A)
3.53
(3.79)
7.37% Details